First Citizens shares leap on SVB deal as Novartis stock boosted by breast-cancer drug trial

by user

[ad_1]

Here were some of the most active stocks in premarket trade, as U.S. stock index futures were boosted on improving news from the banking sector.

Stock gainers:

First Citizens Bancshares stock
FCNCA,
-1.11%

jumped 26% as the North Carolina bank is buying $72 billion of assets from the fallen Silicon Valley Bank at a $16.5 billion discount, the Federal Deposit Insurance Corp. announced.

Regional banks surged. First Republic
FRC,
-1.36%

stock rose 28% and Western Alliance Bancorp
WAL,
+5.76%

rose 6%.

Silvergate Capital
SI,
+52.21%
,
the parent of failed Silvergate Bank, saw its shares rise 16%.

Novartis
NVS,
+1.31%

shares rallied 7% as the drugmaker reported positive trial data on a breast-cancer drug.

Stock losers:

BioNTech
BNTX,
-0.92%

stock weakened 2%. The German vaccine maker reported profit and sales ahead of forecasts, but estimated €5 billion ($5.4 billion) of COVID-19 vaccine revenue this year, down from €17.2 billion in 2022. It also said a renegotiation of the existing supply contract with the European Union may lead to a rephasing of dose deliveries across multiple years and/or volume reduction.

Pharming stock
PHAR,
+32.74%

fell 14%, after surging 33% on Friday when the Food and Drug Administration approved a drug for APDS, a rare and progressive primary immunodeficiency.

[ad_2]

Source link

Related Posts

Leave a Review

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy